{"id":2016,"date":"2020-11-05T10:35:35","date_gmt":"2020-11-05T18:35:35","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=2016"},"modified":"2020-11-06T10:36:27","modified_gmt":"2020-11-06T18:36:27","slug":"repeated-cross-sectional-sero-monitoring-of-sars-cov-2-in-new-york-city","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/11\/05\/repeated-cross-sectional-sero-monitoring-of-sars-cov-2-in-new-york-city\/","title":{"rendered":"Repeated Cross-Sectional Sero-Monitoring of SARS-CoV-2 in New York City"},"content":{"rendered":"<ul>\n<li>Repeat cross-sectional serosurveys conducted from February to July of residual clinical samples from two patient groups in a New York Hospital &#8212; 1) an urgent care (UC) group, enriched with COVID-19 cases, and 2) a routine care (RC) group, which resembles the general population &#8212; identified seropositive samples from mid-February, though the first case of COVID-19 in New York City was not confirmed until March 1. Following peaks in March-April, seroprevalence then declined to slightly above 20% through July in both groups, which the authors note as significantly lower than what would be required for herd immunity.<\/li>\n<\/ul>\n<p>Stadlbauer et al. (Nov 3, 2020). Repeated Cross-Sectional Sero-Monitoring of SARS-CoV-2 in New York City. Nature. <a href=\"https:\/\/doi.org\/10.1038\/s41586-020-2912-6\">https:\/\/doi.org\/10.1038\/s41586-020-2912-6<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Repeat cross-sectional serosurveys conducted from February to July of residual clinical samples from two patient groups in a New York Hospital &#8212; 1) an urgent care (UC) group, enriched with COVID-19 cases, and 2) a routine care (RC) group, which resembles the general population &#8212; identified seropositive samples from mid-February, though the first case of&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/11\/05\/repeated-cross-sectional-sero-monitoring-of-sars-cov-2-in-new-york-city\/\">Read more<\/a><\/div>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[83],"topic":[21],"class_list":["post-2016","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-seroprevalence","topic-transmission"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/2016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=2016"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/2016\/revisions"}],"predecessor-version":[{"id":2017,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/2016\/revisions\/2017"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=2016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=2016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=2016"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=2016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}